Associations between drug and alcohol use, smoking, and frailty among people with HIV across the United States in the current era of antiretroviral treatment
- PMID: 36215811
- PMCID: PMC10088427
- DOI: 10.1016/j.drugalcdep.2022.109649
Associations between drug and alcohol use, smoking, and frailty among people with HIV across the United States in the current era of antiretroviral treatment
Abstract
Objective: To examine associations between frailty and drug, alcohol, and tobacco use among a large diverse cohort of people with HIV (PWH) in clinical care in the current era.
Methods: PWH at 7 sites across the United States completed clinical assessments of patient-reported measures and outcomes between 2016 and 2019 as part of routine care including drug and alcohol use, smoking, and other domains. Frailty was assessed using 4 of the 5 components of the Fried frailty phenotype and PWH were categorized as not frail, pre-frail, or frail. Associations of substance use with frailty were assessed with multivariate Poisson regression.
Results: Among 9336 PWH, 43% were not frail, 44% were prefrail, and 13% were frail. Frailty was more prevalent among women, older PWH, and those reporting current use of drugs or cigarettes. Current methamphetamine use (1.26: 95% CI 1.07-1.48), current (1.65: 95% CI 1.39-1.97) and former (1.21:95% CI 1.06-1.36) illicit opioid use, and former cocaine/crack use (1.17: 95% CI 1.01-1.35) were associated with greater risk of being frail in adjusted analyses. Current smoking was associated with a 61% higher risk of being frail vs. not frail (1.61: 95% CI 1.41-1.85) in adjusted analyses.
Conclusions: We found a high prevalence of prefrailty and frailty among a nationally distributed cohort of PWH in care. This study identified distinct risk factors that may be associated with frailty among PWH, many of which, such as cigarette smoking and drug use, are potentially modifiable.
Keywords: Alcohol use; Cigarette smoking; Frailty; HIV; Methamphetamine use; Substance use.
Copyright © 2022. Published by Elsevier B.V.
Conflict of interest statement
Conflict of interest All authors report that they have no relevant conflicts of interest to disclose.
Similar articles
-
Alcohol Consumption and Illicit Drug Use: Associations With Fall, Fracture, and Acute Health Care Utilization Among People With HIV Infection.J Acquir Immune Defic Syndr. 2024 Apr 1;95(4):391-398. doi: 10.1097/QAI.0000000000003372. J Acquir Immune Defic Syndr. 2024. PMID: 38133581 Free PMC article.
-
Frailty and prefrailty phenotypes increase the odds of abnormal cognitive impairment screens in people with HIV.AIDS. 2023 Nov 15;37(14):2161-2168. doi: 10.1097/QAD.0000000000003681. Epub 2023 Aug 2. AIDS. 2023. PMID: 37534690
-
Frailty and health-related quality of life among older people living with HIV pre- and post-COVID-19 pandemic onset: A cross-sectional study.Braz J Infect Dis. 2024 Jan-Feb;28(1):103723. doi: 10.1016/j.bjid.2024.103723. Epub 2024 Feb 15. Braz J Infect Dis. 2024. PMID: 38369295 Free PMC article.
-
Frailty and HIV: Moving from Characterization to Intervention.Curr HIV/AIDS Rep. 2021 Jun;18(3):157-175. doi: 10.1007/s11904-021-00554-1. Epub 2021 Apr 5. Curr HIV/AIDS Rep. 2021. PMID: 33817767 Free PMC article. Review.
-
Frailty in people with HIV: a geriatric syndrome approach to aging with HIV.Curr Opin HIV AIDS. 2025 Jul 1;20(4):344-349. doi: 10.1097/COH.0000000000000943. Epub 2025 Apr 4. Curr Opin HIV AIDS. 2025. PMID: 40184515 Review.
Cited by
-
A genome-wide association study of methamphetamine use among people with HIV.BMC Med Genomics. 2025 Mar 11;18(1):46. doi: 10.1186/s12920-025-02105-8. BMC Med Genomics. 2025. PMID: 40065283 Free PMC article.
-
Effects of cigarette smoking and secondhand smoke exposure on physical frailty development among community-dwelling older adults in Japan: Evidence from a 10-year population-based cohort study.Geriatr Gerontol Int. 2024 Mar;24 Suppl 1(Suppl 1):142-149. doi: 10.1111/ggi.14708. Epub 2023 Oct 26. Geriatr Gerontol Int. 2024. PMID: 37885346 Free PMC article.
-
Prevalence and risk factors of frailty in people experiencing homelessness: A systematic review and meta-analysis.J Frailty Aging. 2025 Apr;14(2):100029. doi: 10.1016/j.tjfa.2025.100029. Epub 2025 Mar 4. J Frailty Aging. 2025. PMID: 40048427 Free PMC article.
-
The lipid research clinics physical activity questionnaire does not accurately measure physical activity in people with HIV.AIDS. 2025 Aug 1;39(10):1392-1396. doi: 10.1097/QAD.0000000000004226. Epub 2025 May 2. AIDS. 2025. PMID: 40327683
-
Frailty Among Sexual and Gender Minority Older Adults: The All of Us Database.J Gerontol A Biol Sci Med Sci. 2023 Oct 28;78(11):2111-2118. doi: 10.1093/gerona/glad149. J Gerontol A Biol Sci Med Sci. 2023. PMID: 37485864 Free PMC article.
References
-
- Ahmed N, Mandel R, Fain MJ, 2007. Frailty: an emerging geriatric syndrome. Am J Med 120(9), 748–753. - PubMed
-
- Ainsworth BE, Jacobs DR Jr., Leon AS, 1993. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc 25(1), 92–98. - PubMed
-
- Akgun KM, Tate JP, Crothers K, Crystal S, Leaf DA, Womack J, Brown TT, Justice AC, Oursler KK, 2014. An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. J Acquir Immune Defic Syndr 67(4), 397–404. - PMC - PubMed
-
- Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R, Collaborative B, 2011. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr 56 Suppl 1, S22–32. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R21 DA047891/DA/NIDA NIH HHS/United States
- K07 CA190529/CA/NCI NIH HHS/United States
- R24 AG044325/AG/NIA NIH HHS/United States
- R01 DA044112/DA/NIDA NIH HHS/United States
- R24 AI067039/AI/NIAID NIH HHS/United States
- U18 HS026154/HS/AHRQ HHS/United States
- UG1 CA189961/CA/NCI NIH HHS/United States
- R01 DA047045/DA/NIDA NIH HHS/United States
- P01 AA029544/AA/NIAAA NIH HHS/United States
- U01 AA020793/AA/NIAAA NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- P30 AI027767/AI/NIAID NIH HHS/United States
- R33 AG067069/AG/NIA NIH HHS/United States
- R01 HL126538/HL/NHLBI NIH HHS/United States
- P30 AI027757/AI/NIAID NIH HHS/United States